tiprankstipranks
Advertisement
Advertisement
Adaptive Biotechnologies management to meet with Craig-Hallum
PremiumThe FlyAdaptive Biotechnologies management to meet with Craig-Hallum
1M ago
Adaptive Biotechnologies offers to sell $250M in 2031 convertible senior notes
Premium
The Fly
Adaptive Biotechnologies offers to sell $250M in 2031 convertible senior notes
1M ago
Adaptive Biotechnologies Plans MRD and Immune Medicine Split
Premium
Company Announcements
Adaptive Biotechnologies Plans MRD and Immune Medicine Split
1M ago
Adaptive Biotechnologies price target raised to $21 from $19 at TD Cowen
PremiumThe FlyAdaptive Biotechnologies price target raised to $21 from $19 at TD Cowen
3M ago
Adaptive Biotechnologies Wins Buy Rating on Surging MRD Revenue, Raised Guidance, and Clear Path to Profitability
Premium
Ratings
Adaptive Biotechnologies Wins Buy Rating on Surging MRD Revenue, Raised Guidance, and Clear Path to Profitability
3M ago
Adaptive Biotechnologies Leans on MRD in Earnings Call
Premium
Company Announcements
Adaptive Biotechnologies Leans on MRD in Earnings Call
3M ago
Adaptive Biotechnologies price target raised to $21 from $20 at JPMorgan
PremiumThe FlyAdaptive Biotechnologies price target raised to $21 from $20 at JPMorgan
6M ago
Adaptive Biotechnologies: Sustained MRD Growth, Pricing Power, and Strategic Positioning Support Buy Rating and Premium Valuation
Premium
Ratings
Adaptive Biotechnologies: Sustained MRD Growth, Pricing Power, and Strategic Positioning Support Buy Rating and Premium Valuation
6M ago
Adaptive Biotechnologies: Strong MRD Momentum, Enhanced 2026 Outlook, and Clear Path to Profitability Support Buy Rating
Premium
Ratings
Adaptive Biotechnologies: Strong MRD Momentum, Enhanced 2026 Outlook, and Clear Path to Profitability Support Buy Rating
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100